[Effect of griseofulvin on the maintainance of thiamine and nicotinic acid reserves in psoriasis patients].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001452:Balneology; D004155:Diphenhydramine / Q000627:therapeutic use; D004341:Drug Evaluation; D004342:Drug Hypersensitivity; D004357:Drug Synergism; D005260:Female; D006118:Griseofulvin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000378:metabolism* / Q000627:therapeutic use; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy* / Q000378:metabolism; D012256:Riboflavin / Q000627:therapeutic use; D013831:Thiamine / Q000378:metabolism* / Q000627:therapeutic use
D009539:Nicotinic Acids; D009824:Ointments; D006118:Griseofulvin; D004155:Diphenhydramine; D012256:Riboflavin; D013831:Thiamine
O vliianii grizeoful'vina na obespechennost' tiaminom i nikotinovoĭ kislotoĭ u bol'nykh psoriazom